Leknessund Oda G R, Morelli Vania M, Hansen John-Bjarne, Brækkan Sigrid K
Thrombosis Research Group, Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Res Pract Thromb Haemost. 2023 Jun 29;7(5):102138. doi: 10.1016/j.rpth.2023.102138. eCollection 2023 Jul.
There is limited information on the relationship between muscle strength and recurrence and mortality after incident venous thromboembolism (VTE).
To investigate whether weak hand grip strength (HGS) was associated with risk of recurrence and mortality in patients with VTE recruited from the general population.
Participants from the Tromsø Study with a first-time VTE ( = 545) were included, and all VTE recurrences and deaths among the participants were recorded in the period 1994 to 2020. Weak HGS was defined as lowest 25th percentile of the general population, and incidence rates for VTE recurrence and mortality according to weak vs normal (>25th percentile) HGS, with 95% CIs, were estimated.
There were 90 recurrences and 350 deaths during a median of 3.7 years of follow-up. The fully adjusted hazard ratio (HR) for overall VTE recurrence for those with weak HGS vs those with normal HGS was 2.02 (95% CI, 1.23-3.30). The corresponding HRs for recurrence were 2.22 (95% CI, 1.18-4.17) in patients with a first deep vein thrombosis and 1.60 (95% CI, 0.72-3.57) in patients with a first pulmonary embolism. The cumulative 1-year survival was 74.9% and 77.8% in those with weak and normal HGS, respectively. For overall mortality after incident VTE, the fully adjusted HR for those with weak HGS was 1.34 (95% CI, 1.04-1.72).
Weak HGS was associated with an increased risk of recurrent VTE, and the association appeared to be particularly pronounced after incident deep vein thrombosis. There was a slightly lower survival probability among those with weak HGS than among those with normal HGS.
关于肌肉力量与新发静脉血栓栓塞症(VTE)后复发及死亡率之间的关系,相关信息有限。
研究普通人群中招募的VTE患者握力弱是否与复发风险及死亡率相关。
纳入特罗姆瑟研究中首次发生VTE的参与者(n = 545),记录1994年至2020年期间参与者的所有VTE复发和死亡情况。握力弱定义为处于普通人群最低的第25百分位数,根据握力弱与正常(>第25百分位数)情况,估计VTE复发和死亡率的发生率及95%置信区间。
在中位3.7年的随访期间,有90例复发和350例死亡。握力弱的患者与握力正常的患者相比,总体VTE复发的完全调整风险比(HR)为2.02(95%置信区间,1.23 - 3.30)。首次发生深静脉血栓形成的患者复发的相应HR为2.22(95%置信区间,1.18 - 4.17),首次发生肺栓塞的患者为1.60(95%置信区间,0.72 - 3.57)。握力弱和正常的患者1年累积生存率分别为74.9%和77.8%。对于新发VTE后的总体死亡率,握力弱的患者完全调整后的HR为1.34(95%置信区间,1.04 - 1.72)。
握力弱与VTE复发风险增加相关,这种关联在首次发生深静脉血栓形成后似乎尤为明显。握力弱的患者生存率略低于握力正常的患者。